Other and unspecified bullous disorders

L12_OTHERBULL

vesiculobullous skin disease: Skin diseases characterized by local or general distributions of vesicles and bullae (i.e. blisters). Both vesicles and bullae are fluid-filled lesions, distinguished by size (vesicles being less than 5–10 mm and bullae being larger than 5–10 mm). Vesiculobullous diseases are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. In the case of vesiculobullous diseases which are also immune disorders, the term immunobullous is sometimes used. (From Scientific American Medicine, 1990, and Wikipedia)

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L13
  • Hospital discharge: ICD-9 694[8-9]
  • Hospital discharge: ICD-8 69409
  • Hospital discharge: excluded ICD-10 L13.0, L13.1
  • Cause of death: ICD-10 L13
  • Cause of death: ICD-9 694[8-9]
  • Cause of death: ICD-8 69409
  • Cause of death: excluded ICD-10 L13.0, L13.1

2 out of 7 registries used, show all original rules.

342

4. Check minimum number of events

None

342

5. Include endpoints

None

342

6. Filter based on genotype QC (FinnGen only)

342

Control definitions (FinnGen only)

Control exclude
L12_BULLOUS

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
L10-L14
Name in latin
Aliae morbositates bullosae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2861 1586 1258
Only index persons 2371 1363 1008
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.04
Only index persons 0.05 0.05 0.04
Median age at first event (years)
Whole population 55.73 56.47 54.87
Only index persons 56.95 56.76 57.21

-FinnGen-

Key figures

All Female Male
Number of individuals 342 207 135
Unadjusted period prevalence (%) 0.07 0.07 0.06
Median age at first event (years) 59.96 56.86 64.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
302
Matched controls
3019
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L13.9
ICD-10 Finland
Bullous disorder, unspecified
10684.7
298.3
236
*
L13.8
ICD-10 Finland
Other specified bullous disorders
665.8
57.6
55
*
L12.0
ICD-10 Finland
Bullous pemphigoid
+∞
49.3
46
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.4
38.7
94
154
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.0
28.3
109
309
J04BA02
ATC
dapsone; oral
98.5
25.1
27
*
L13.0
ICD-10 Finland
Dermatitis herpetiformis
271.5
25.1
25
*
TQW80
NOMESCO Finland
Local dermatologic skincare
13.0
23.0
41
36
D07AC01
ATC
betamethasone; topical
3.5
22.6
150
664
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
4.9
21.6
78
199
L12.9
ICD-10 Finland
Pemphigoid, unspecified
+∞
16.8
16
*
D07AD01
ATC
clobetasol; topical
3.7
16.5
81
271
E0000UV
ATC
NA
2.8
15.6
155
835
H02AB06
ATC
prednisolone; systemic
2.7
15.2
176
1034
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.2
15.2
37
57
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
12.5
124
644
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
12.5
65
224
D07AC13
ATC
mometasone; topical
2.6
12.3
110
539
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.9
12.0
51
148
D07AB08
ATC
desonide; topical
4.1
11.8
48
134
A46
ICD-10 Finland
Erysipelas
3.2
10.8
63
232
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.5
10.6
51
164
S97
ICPC
Chronic ulcer skin
5.2
10.4
32
67
XQ802
NOMESCO Finland
Epicutan test
6.2
9.9
26
45
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
9.8
52
180
E000001
ATC
NA
2.6
9.8
82
381
D07AB02
ATC
hydrocortisone butyrate; topical
2.4
9.7
105
557
S18
ICPC
Laceration/cut
2.2
9.7
143
874
J01FF01
ATC
clindamycin; systemic
2.4
9.7
103
542
J01DB01
ATC
cefalexin; oral
2.7
9.6
258
2078
R06AE07
ATC
cetirizine; oral
2.1
8.9
148
945
R50.9
ICD-10 Finland
Fever, unspecified
2.8
8.8
60
244
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.4
8.7
43
141
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.7
88
446
J05AB11
ATC
valaciclovir; oral
3.0
8.7
53
201
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
10.5
8.6
16
16
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
8.3
68
306
D02AX
ATC
Other emollients and protectives
5.7
8.3
23
43
L30.3
ICD-10 Finland
Infective dermatitis
6.0
8.3
22
39
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
7.9
39
128
ZX120
NOMESCO Finland
Intravenous
3.1
7.8
44
158
XQ848
NOMESCO Finland
Dermatological photography
5.6
7.5
21
40
J01MA12
ATC
levofloxacin; systemic
2.5
7.5
66
309
L13
ICD-10 Finland
Other bullous disorders
82.0
7.4
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
7.4
45
170
S29
ICPC
Skin symptom/complaint other
2.5
7.3
61
279
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
7.3
141
930
A02BC02
ATC
pantoprazole; systemic
2.0
7.3
196
1463
C03CA01
ATC
furosemide; systemic
2.1
7.1
97
558
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
7.1
53
227
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.4
7.0
24
58
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.1
6.8
20
41
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
6.8
39
143
H3600, E103
ICD-10 Finland
NA
17.2
6.8
10
6
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
41.0
6.8
8
*
A10AE05
ATC
insulin detemir; parenteral
4.1
6.8
25
65
H02AB04
ATC
methylprednisolone; systemic
2.4
6.8
57
262
N02BE01
ATC
paracetamol; systemic, rectal
2.3
6.6
261
2219
D05BB02
ATC
acitretin; oral
7.1
6.6
15
22
H04.10
ICD-10 Finland
Dry eye syndrome
2.9
6.5
38
141
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
6.5
48
205
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.3
6.4
31
101
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
6.4
77
418
P01BA02
ATC
hydroxychloroquine; oral
3.1
6.3
35
123
L73.8
ICD-10 Finland
Other specified follicular disorders
27.3
6.3
8
*
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
27.3
6.3
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.2
40
158
Z3231
NOMESCO Finland
Registered nurse
2.0
6.1
92
547
ZY010
NOMESCO Finland
Hospital outpatient
3.7
6.1
25
72
H02AB09
ATC
hydrocortisone; systemic
5.8
6.1
16
29
J01MA02
ATC
ciprofloxacin; systemic
1.9
6.1
124
821
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
6.0
93
556
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.1
6.0
22
57
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
6.0
61
304

Mortality – FinRegistry

Association

Association between endpoint L12_OTHERBULL and mortality.

Females

Parameter HR [95% CI] p-value
L12_OTHERBULL 1.902 [1.48, 2.45] < 0.001
Birth year 0.992 [0.98, 1.0] 0.074

During the follow-up period (1.1.1998 — 31.12.2019), 276 out of 1248 females with L12_OTHERBULL died.

Males

Parameter HR [95% CI] p-value
L12_OTHERBULL 2.2 [1.6, 3.02] < 0.001
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 245 out of 961 males with L12_OTHERBULL died.

Mortality risk

Mortality risk for people of age

years, who have L12_OTHERBULL.

N-year risk Females Males
1 0.175% 0.288%
5 1.006% 2.259%
10 2.608% 6.262%
15 4.971% 11.153%
20 8.711% 18.21%

Relationships between endpoints

Index endpoint: L12_OTHERBULL – Other and unspecified bullous disorders

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data